PTO user fees to be devoted solely to agency after FY 1998 under budget agreement.
PTO USER FEE SURCHARGE TO END AFTER FY 1998 UNDER BUDGET AGREEMENT reached between Congressional Republicans and the White House, Senate Judiciary Committee Chairman Hatch (R-Utah) reported at a May 7 hearing on Hatch's Omnibus Patent Act of 1997 (S 507). "I have been working with the Chairman of the Senate Budget Committee, Sen. Domenici [R-N.M.] to make certain that the surcharge is not extended," Hatch said. "I am happy to say that the budget agreement announced last week envisions an end to the surcharge after fiscal year 1998 and I will continue to be vigilant to ensure that does not change."
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth